Ostomy Care And Accessories Market

Publisher Grand View Research

Published Mar 05, 2026

Length 145 Pages

SKU # GV21085186

Description

Ostomy Care And Accessories Market Size, Share & Trends Analysis Report By Product (Bags, Accessories), By Application (Colostomy, Ileostomy, Urostomy), By End Use (Home Care Settings, Hospitals), By Region, And Segment Forecasts, 2026 - 2033

Ostomy Care And Accessories Market Summary

The global ostomy care and accessories market size was estimated at USD 4.1 billion in 2025 and is projected to reach USD 6.3 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033. The demand for ostomy care and accessories is anticipated to increase owing to a rise in the number of patients suffering from urological diseases such as bladder cancer and colorectal cancer, an increase in the number of ostomy surgeries, and technological advancements.

According to the data published by Nebraska Medicine in December 2024, about 725,000 to 1 million individuals in the U.S. have a permanent or temporary ostomy, and 100,000 ostomy surgeries are conducted yearly. In addition, the rising geriatric population base is further expected to drive the demand for ostomy care and accessories over the forecast period.

A rising number of initiatives being undertaken by various private players and nonprofit organizations to raise awareness regarding ostomy care across the globe is anticipated to drive the demand for ostomy care products. For instance, theUnited Ostomy Associations of America (UOAA) celebrated Ostomy Awareness Day in 2024 with several initiatives, including:

Encouraging individuals to share their personal stories of how having an ostomy has transformed their lives using the hashtags #OstomiesAreLifesavers, #IAmLivingProof, and #OstomyDay2024 on social media while tagging UOAA.
Promoting sharing "Stickers" or Ostomy Facts on social media platforms.
Raising funds for the ostomy awareness initiative.

These activities help break down stigmas and increase awareness of ostomy procedures worldwide. An increasing prevalence of colorectal cancer is expected to drive the demand for the industry. For instance, according to the WHO data published in July 2023, colorectal cancer is the second leading cause of cancer-related deaths globally. In addition, according to data released by the University of Washington in March 2024, colorectal cancer is projected to become the leading cause of cancer-related deaths in the U.S. among individuals under 50 by 2030. The report also reveals that the incidence of colorectal cancer has increased by 50% over the past 30 years among this age group.

Global Ostomy Care And Accessories Market Report Segmentation

This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ostomy care and accessories market report based on product, application, end use, and region:

Product Outlook (Volume Unit; Revenue, USD Million, 2021 - 2033)
Bags
One Piece
Two Piece
Accessories
Seals/Barrier Rings
Pouch Cover
Pouch Closures
Stoma Caps/Hat
Others
Application Outlook (Volume Unit; Revenue, USD Million, 2021 - 2033)
Colostomy
Ileostomy
Urostomy
End Use Outlook (Volume Unit; Revenue, USD Million, 2021 - 2033)
Home Care Settings
Hospitals
Others
Regional Outlook (Volume Unit; Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.1.1. Product; 1.1.2. Application; 1.1.3. End use; 1.1.4. Regional scope; 1.1.5. Estimates and forecast timeline; 1.2. Research Methodology; 1.3. Information Procurement; 1.3.1. Purchased database; 1.3.2. GVR’s internal database; 1.3.3. Secondary sources; 1.3.4. Primary research; 1.3.5. Details of primary research; 1.4. Information or Data Analysis; 1.4.1. Data analysis models; 1.5. Market Formulation & Validation; 1.6. Model Details; 1.6.1. Commodity flow analysis (Model 1); 1.6.1.1. Approach 1: Commodity flow approach; 1.6.2. Volume price analysis (Model 2); 1.6.2.1. Approach 2: Volume price analysis; 1.7. List of Secondary Sources; 1.8. List of Primary Sources; 1.9. Objectives; 1.9.1. Objective 1; 1.9.2. Objective 2
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Product outlook; 2.2.2. Application outlook; 2.2.3. End use outlook; 2.2.4. Regional outlook; 2.3. Competitive Insights
Chapter 3. Ostomy Care And Accessories Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent market outlook; 3.1.2. Related/ancillary market outlook; 3.2. Patient Population by Category: Total Population, New Patient Discharged and Per Pathology (2021 - 2033); 3.3. Market Dynamics; 3.3.1. Market driver analysis; 3.3.1.1. Rising awareness initiatives for ostomy; 3.3.1.2. Development of digital platforms for ostomy care; 3.3.1.3. Increasing burden of target diseases; 3.3.1.4. Growing funding for ostomy products; 3.3.1.5. Availability of reimbursement for ostomy care; 3.3.2. Market restraint analysis; 3.3.2.1. Product recalls and alerts; 3.3.3. Market opportunity analysis; 3.3.3.1. Developments of 3D printed and customized ostomy bags; 3.3.3.2. Advancements in filtration technology; 3.3.3.3. Increasing clinical trials for ostomy bags; 3.3.3.4. Expansion of product portfolios; 3.3.4. Market challenge analysis; 3.3.4.1. Common issues and side effects associated with ostomy; 3.4. Ostomy Care And Accessories Market Analysis Tools; 3.4.1. Industry Analysis - Porter’s; 3.4.1.1. Supplier power; 3.4.1.2. Buyer power; 3.4.1.3. Substitution threat; 3.4.1.4. Threat of new entrant; 3.4.1.5. Competitive rivalry; 3.4.2. PESTEL Analysis; 3.4.2.1. Political landscape; 3.4.2.2. Technological landscape; 3.4.2.3. Economic landscape
Chapter 4. Ostomy Care And Accessories Market: Product Estimates & Trend Analysis: 4.1. Definitions and Scope; 4.1.1. Bags; 4.1.2. Accessories; 4.2. Product Market Share, 2021 & 2033; 4.3. Segment Dashboard; 4.4. Global Surgical Refractor Market by Product Outlook; 4.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following; 4.5.1. Bags; 4.5.1.1. Bags market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.1.2. One- Piece; 4.5.1.2.1 One-piece market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.1.3. Two- Piece; 4.5.1.3.1 Two-piece market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.2. Accessories; 4.5.2.1. Accessories market estimates and forecast 2021 to 2033s, (USD Million, Volume Unit); 4.5.2.2. Seals/Barrier Rings; 4.5.2.2.1 Seals/barrier rings market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.2.3. Pouch Cover; 4.5.2.3.1 Pouch cover market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.2.4. Pouch Closures; 4.5.2.4.1 Pouch closures market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.2.5. Stoma Caps/Hat; 4.5.2.5.1 Stoma caps/hat market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 4.5.2.6. Others; 4.5.2.6.1 Others market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
Chapter 5. Ostomy Care And Accessories Market: Application Estimates & Trend Analysis: 5.1. Definitions and Scope; 5.1.1. Colostomy; 5.1.2. Ileostomy; 5.1.3. Urostomy; 5.2. Application Market Share, 2021 & 2033; 5.3. Segment Dashboard; 5.4. Global Ostomy Care And Accessories Market by Application Outlook; 5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following; 5.5.1. Colostomy; 5.5.1.1. Colostomy market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 5.5.2. Ileostomy; 5.5.2.1. Ileostomy market estimates and forecast 2021 to 2033 (USD Million, Volume Unit; 5.5.3. Urostomy; 5.5.3.1. Urostomy market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
Chapter 6. Ostomy Care And Accessories: End Use Estimates & Trend Analysis: 6.1. Definitions and Scope; 6.1.1. Home Care Settings; 6.1.2. Hospitals; 6.1.3. Others; 6.2. End Use Market Share, 2021 & 2033; 6.3. Segment Dashboard; 6.4. Global Ostomy Care And Accessories Market by End Use Outlook; 6.5. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following; 6.5.1. Home Care Settings; 6.5.1.1. Home care settings market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 6.5.2. Hospitals; 6.5.2.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million, Volume Unit); 6.5.3. Others; 6.5.3.1. Others market estimates and forecast 2021 to 2033 (USD Million, Volume Unit)
Chapter 7. Ostomy Care And Accessories Market: Regional Estimates & Trend Analysis: 7.1. Regional Market Share Analysis, 2021 & 2033; 7.2. Regional Market Dashboard; 7.3. Global Regional Market Snapshot; 7.4. Market Size, & Forecasts Trend Analysis, 2025 to 2033:; 7.5. North America; 7.5.1. U.S.; 7.5.1.1. U.S. market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.5.2. Canada; 7.5.2.1. Canada market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.5.3. Mexico; 7.5.3.1. Mexico market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6. Europe; 7.6.1. UK; 7.6.1.1. UK market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.2. Germany; 7.6.2.1. Germany market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.3. France; 7.6.3.1. France market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.4. Italy; 7.6.4.1. Italy market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.5. Spain; 7.6.5.1. Spain market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.6. Norway; 7.6.6.1. Norway market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.7. Sweden; 7.6.7.1. Sweden market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.6.8. Denmark; 7.6.8.1. Denmark market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7. Asia Pacific; 7.7.1. Japan; 7.7.1.1. Japan market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7.2. China; 7.7.2.1. China market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7.3. India; 7.7.3.1. India market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7.4. Australia; 7.7.4.1. Australia market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7.5. South Korea; 7.7.5.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.7.6. Thailand; 7.7.6.1. Thailand market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.8. Latin America; 7.8.1. Brazil; 7.8.1.1. Brazil market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.8.2. Argentina; 7.8.2.1. Argentina market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.9. MEA; 7.9.1. South Africa; 7.9.1.1. South Africa market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.9.2. Saudi Arabia; 7.9.2.1. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.9.3. UAE; 7.9.3.1. UAE market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit); 7.9.4. Kuwait; 7.9.4.1. Kuwait market estimates and forecast, 2021 - 2033 (USD Million, Volume Unit)
Chapter 8. Competitive Landscape: 8.1. Recent Developments & Impact Analysis, By Key Market Participants; 8.2. Company/Competition Categorization; 8.2.1. Innovators; 8.3. ACE Matrix; 8.4. Vendor Landscape; 8.4.1. List of key distributors and channel partners; 8.4.2. Key customers; 8.4.3. Global Key company market share analysis, 2025; 8.4.3.1. North America key company market share analysis, 2025; 8.4.3.1.1. Coloplast; 8.4.3.1.2. ConvaTec Inc.; 8.4.3.1.3. Hollister Incorporated; 8.4.3.1.4. Marlen Manufacturing & Development Company; 8.4.3.1.5. Nu-Hope Laboratories, Inc.; 8.4.3.1.6. Schena Ostomy Technologies, Inc.; 8.4.3.1.7. Eakin Healthcare Group; 8.4.3.1.8. Welland Medical Limited; 8.4.3.1.9. Cymed; 8.4.3.1.10. Torbot Group, Inc.; 8.4.3.2. Europe key company market share analysis, 2025; 8.4.3.2.1. Casex; 8.4.3.2.2. Salts Healthcare; 8.4.3.2.3. Eakin Healthcare Group; 8.4.3.2.4. Welland Medical Limited; 8.4.3.2.5. B.Braun SE; 8.4.3.2.6. Coloplast; 8.4.3.2.7. Convatec Inc.; 8.4.3.2.8. Hollister Incorporated; 8.4.3.2.9. Marlen Manufacturing & Development Company; 8.4.3.2.10. Ostique Limited; 8.4.3.3. Asia Pacific key company market share analysis, 2025; 8.4.3.3.1. Eakin Healthcare Group; 8.4.3.3.2. Prowess Care; 8.4.3.3.3. ALCARE Co., Ltd; 8.4.3.3.4. Welland Medical Limited.; 8.4.3.3.5. Hollister Incorporated; 8.4.3.3.6. Marlen Manufacturing & Development Company; 8.4.3.3.7. B.Braun SE; 8.4.3.3.8. Coloplast; 8.4.3.3.9. Convatec Inc; 8.4.3.3.10. Batel Plus Corporation.; 8.4.3.4. Latin America key company market share analysis, 2025; 8.4.3.4.1. Casex; 8.4.3.4.2. Welland Medical Limited; 8.4.3.4.3. B. Braun Laboratories; 8.4.3.4.4. Coloplast; 8.4.3.4.5. Convatec Inc.; 8.4.3.4.6. Hollister Incorporated; 8.4.3.4.7. Salts Healthcare (Life Santé); 8.4.3.5. Middle East & Africa key company market share analysis, 2025; 8.4.3.5.1. Eakin Healthcare Group; 8.4.3.5.2. Welland Medical Limited; 8.4.3.5.3. B. Braun SE; 8.4.3.5.4. Coloplast; 8.4.3.5.5. Convatec Inc.; 8.4.3.5.6. HARTMANN South Africa; 8.4.4. Global Key company market share analysis, 2025; 8.4.5. Coloplast; 8.4.5.1. SWOT Analysis; 8.4.5.2. Company overview; 8.4.5.3. Financial performance; 8.4.5.4. Product benchmarking; 8.4.5.5. Strategic initiatives; 8.4.6. ConvaTec Inc.; 8.4.6.1. SWOT Analysis; 8.4.6.2. Company overview; 8.4.6.3. Financial performance; 8.4.6.4. Product benchmarking; 8.4.6.5. Strategic initiatives; 8.4.7. Hollister Incorporated; 8.4.7.1. SWOT Analysis; 8.4.7.2. Company overview; 8.4.7.3. Financial performance; 8.4.7.4. Product benchmarking; 8.4.7.5. Strategic initiatives; 8.4.8. Marlen Manufacturing & Development Company; 8.4.8.1. SWOT Analysis; 8.4.8.2. Company overview; 8.4.8.3. Financial performance; 8.4.8.4. Product benchmarking; 8.4.8.5. Strategic initiatives; 8.4.9. Nu-Hope Laboratories, Inc.; 8.4.9.1. SWOT Analysis; 8.4.9.2. Company overview; 8.4.9.3. Financial performance; 8.4.9.4. Product benchmarking; 8.4.9.5. Strategic initiatives; 8.4.10. Safe n' Simple; 8.4.10.1. SWOT Analysis; 8.4.10.2. Company overview; 8.4.10.3. Financial performance; 8.4.10.4. Product benchmarking; 8.4.10.5. Strategic initiatives; 8.4.11. Schena Ostomy Technologies, Inc.; 8.4.11.1. SWOT Analysis; 8.4.11.2. Company overview; 8.4.11.3. Financial performance; 8.4.11.4. Product benchmarking; 8.4.11.5. Strategic initiatives; 8.4.12. Casex; 8.4.12.1. SWOT Analysis; 8.4.12.2. Company overview; 8.4.12.3. Financial performance; 8.4.12.4. Product benchmarking; 8.4.12.5. Strategic initiatives; 8.4.13. Eakin; 8.4.13.1. SWOT Analysis; 8.4.13.2. Company overview; 8.4.13.3. Financial performance; 8.4.13.4. Product benchmarking; 8.4.13.5. Strategic initiatives; 8.4.14. Alcare; 8.4.14.1. SWOT Analysis; 8.4.14.2. Company overview; 8.4.14.3. Financial performance; 8.4.14.4. Product benchmarking; 8.4.14.5. Strategic initiatives; 8.4.15. Welland Medical Limited; 8.4.15.1. SWOT Analysis; 8.4.15.2. Company overview; 8.4.15.3. Financial performance; 8.4.15.4. Product benchmarking; 8.4.15.5. Strategic initiatives; 8.4.16. B.Braun SE; 8.4.16.1. SWOT Analysis; 8.4.16.2. Company overview; 8.4.16.3. Financial performance; 8.4.16.4. Product benchmarking; 8.4.16.5. Strategic initiatives; 8.4.17. Cymed; 8.4.17.1. SWOT Analysis; 8.4.17.2. Company overview; 8.4.17.3. Financial performance; 8.4.17.4. Product benchmarking; 8.4.17.5. Strategic initiatives; 8.4.18. Torbot Group, Inc.; 8.4.18.1. SWOT Analysis; 8.4.18.2. Company overview; 8.4.18.3. Financial performance; 8.4.18.4. Product benchmarking; 8.4.18.5. Strategic initiatives; 8.4.19. Salts Healthcare; 8.4.19.1. SWOT Analysis; 8.4.19.2. Company overview; 8.4.19.3. Financial performance; 8.4.19.4. Product benchmarking; 8.4.19.5. Strategic initiatives; 8.4.20. Prowess Care; 8.4.20.1. SWOT Analysis; 8.4.20.2. Company overview; 8.4.20.3. Financial performance; 8.4.20.4. Product benchmarking; 8.4.20.5. Strategic initiatives; 8.4.21. Batel Plus Corporation; 8.4.21.1. SWOT Analysis; 8.4.21.2. Company overview; 8.4.21.3. Financial performance; 8.4.21.4. Product benchmarking; 8.4.21.5. Strategic initiatives; 8.4.22. Ostique Limited; 8.4.22.1. SWOT Analysis; 8.4.22.2. Company overview; 8.4.22.3. Financial performance; 8.4.22.4. Product benchmarking; 8.4.22.5. Strategic initiatives; 8.4.23. HARTMANN South Africa; 8.4.23.1. SWOT Analysis; 8.4.23.2. Company overview; 8.4.23.3. Financial performance; 8.4.23.4. Product benchmarking; 8.4.23.5. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $6,950
Multi License Fulfilled by Publisher $7,950
Global Site License Email from Publisher $9,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now